Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3

Review

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

         
Total article views   Abstract views HTML views PDF downloads Totals
10,773 Dovepress* 8,963 566+ 4,321 9,529
PubMed Central* 0 1,244 92 1,244
Totals 8,963 1,810 4,413 10,773
*Since 4 August 2011
+Since July 2016

View citations on PubMed Central and Google Scholar